Target intelligence / Profile preview

Ubiquitin-conjugating enzyme E2K pseudogene (null)

Target
null
Molecular classification
Pseudogene
01

Overview

The ubiquitin-conjugating enzyme E2K pseudogene is a non-functional DNA segment with high sequence homology to the functional UBE2K gene, which encodes an enzyme involved in protein ubiquitination. Pseudogenes generally result from gene duplication or retrotransposition events and typically accumulate mutations rendering them unable to produce functional proteins. While most pseudogenes do not serve therapeutic or biomarker roles, some can be transcribed into non-coding RNA with potential regulatory effects, but there is no evidence that this particular pseudogene (ENSG00000276563) has any functional relevance or therapeutic potential. These sequences can complicate genetic studies due to their similarity to protein-coding genes. The canonical, protein-coding version relevant to disease and drug interactions is UBE2K, not its pseudogene copy.

Other names
UBE2K pseudogeneE2K pseudogene
02

Mechanism of action

null

Beyond the preview

Go deeper on Ubiquitin-conjugating enzyme E2K pseudogene (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin-conjugating enzyme E2K pseudogene (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call